Latest News and Press Releases
Want to stay updated on the latest news?
-
CAMBRIDGE, Mass., Jan. 16, 2019 (GLOBE NEWSWIRE) -- VBI Vaccines Inc. (Nasdaq: VBIV) (“VBI”), a commercial-stage biopharmaceutical company developing next-generation infectious disease and...
-
About 40% of Big-Company Mergers Require a Turnaround; Risks are Big, but Rewards Can be Greater, According to BCG TURN Report That Brings to Life Eight Successes BOSTON, Nov. 19, 2018 (GLOBE...
-
CAMBRIDGE, Mass., Aug. 15, 2018 (GLOBE NEWSWIRE) -- VBI Vaccines Inc. (NASDAQ: VBIV) (“VBI”), a commercial-stage biopharmaceutical company, today announced the appointment of Christopher McNulty as...
-
CAMBRIDGE, MA--(Marketwire - April 6, 2011) - On April 11, the MIT Enterprise Forum of Cambridge will feature a keynote by Chris Viehbacher, CEO of Sanofi-aventis. Headquartered in Paris, France,...